Steven Cohen Pacira Bio Sciences, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $20.1 Million - $29.7 Million	-632,200 Reduced 80.82%	150,000 $6.85 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $27.9 Million - $30.9 Million	782,200	782,200 $29.4 Million

256

48.3M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.18B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.